Marimed (MRMD) Amortizatization of Intangibles (2021 - 2026)
Marimed (MRMD) posted quarterly Amortizatization of Intangibles of $115000.0 for Q1 2026, up 9.52% year-over-year from $105000.0 in Q1 2025, and down 4.17% quarter-over-quarter from $120000.0 in Q4 2025.
Marimed (MRMD) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Marimed (MRMD) has reported Amortizatization of Intangibles for 5 consecutive years, with $115000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 9.52% year-over-year to $115000.0; the TTM figure through Mar 2026 stood at $469000.0 (up 24.73% YoY), while the FY2025 annual figure was $459000.0, up 28.21% from the prior year.
- Amortizatization of Intangibles slipped to $115000.0 in Q1 2026 per MRMD's latest filing, from $120000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $1.3 million in Q2 2023 and bottomed at $87000.0 in Q1 2024.
- Historically, Amortizatization of Intangibles has averaged $291000.0 across 4 years, with a median of $117000.0 in 2025.
- Annual changes were most pronounced in 2024 — Amortizatization of Intangibles sank 93.12% — and 2025, when it soared 32.95%.
- Marimed's Amortizatization of Intangibles stood at $292000.0 in 2023, then tumbled by 68.15% to $93000.0 in 2024, then climbed by 29.03% to $120000.0 in 2025, then fell by 4.17% to $115000.0 in 2026.
- Business Quant data shows MRMD's Amortizatization of Intangibles at $115000.0 in Q1 2026, $120000.0 in Q4 2025, and $117000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Marimed | 30.77 Mn | 22.33 Mn | 16.23 Mn | 196,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 196,000.00 |
| Jun 30, 2026 | 196,000.00 |
| Mar 31, 2026 | 115,000.00 |
| Mar 31, 2026 | 115,000.00 |
| Dec 31, 2025 | 120,000.00 |
| Dec 31, 2025 | 120,000.00 |
| Sep 30, 2025 | 117,000.00 |
| Sep 30, 2025 | 117,000.00 |
| Jun 30, 2025 | 117,000.00 |
| Jun 30, 2025 | 117,000.00 |
| Mar 31, 2025 | 105,000.00 |
| Mar 31, 2025 | 105,000.00 |
| Dec 31, 2024 | 93,000.00 |
| Dec 31, 2024 | 93,000.00 |
| Sep 30, 2024 | 90,000.00 |
| Sep 30, 2024 | 90,000.00 |
| Jun 30, 2024 | 88,000.00 |
| Jun 30, 2024 | 88,000.00 |
| Mar 31, 2024 | 87,000.00 |
| Mar 31, 2024 | 87,000.00 |